Table 2.
H1N1 | H3N2 | B | |
---|---|---|---|
Seroconversion | 28% | 66% | 31% |
VES-13 | + | NS | NS |
BMI ≥ 30 kg/m2 | NS | + | NS |
Age | NS | NS | NS |
Gender | NS | NS | NS |
Comorbidities | NS | NS | NS |
Seroprotection | 44% | 78% | 95% |
VES-13 | NS | NS | ND |
BMI ≥ 30 kg/m2 | NS | NS | ND |
Age | NS | NS | ND |
Gender | NS | NS | ND |
Comorbidities | NS | NS | ND |
Post-vaccination HAI titer | |||
VES-13 | + | NS | NS |
BMI ≥ 30 kg/m2 | NS | + | NS |
Age | NS | NS | − |
Gender | NS | − | NS |
Comorbidities | NS | NS | NS |
NS not significant
ND not done due to high proportion of seroprotected subjects
+ direct association